44.40
3.24 (7.87%)
| Previous Close | 41.16 |
| Open | 40.67 |
| Volume | 606,791 |
| Avg. Volume (3M) | 338,771 |
| Market Cap | 1,286,300,672 |
| Price / Sales | 6.85 |
| Price / Book | 53.75 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 |
| Profit Margin | -52.34% |
| Operating Margin (TTM) | -40.96% |
| Diluted EPS (TTM) | -3.12 |
| Quarterly Revenue Growth (YOY) | 11.30% |
| Total Debt/Equity (MRQ) | 585.48% |
| Current Ratio (MRQ) | 3.36 |
| Operating Cash Flow (TTM) | -68.09 M |
| Levered Free Cash Flow (TTM) | -44.94 M |
| Return on Assets (TTM) | -11.43% |
| Return on Equity (TTM) | -186.68% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Establishment Labs Holdings Inc | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 5.0 |
| Insider Activity | 1.5 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | 2.00 |
|
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 10.75% |
| % Held by Institutions | 106.06% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Jw Asset Management, Llc | 30 Jun 2025 | 3,092,485 |
| Brown Advisory Inc | 30 Jun 2025 | 2,145,162 |
| Findell Capital Management Llc | 30 Jun 2025 | 1,379,480 |
| Tyro Capital Management Llc | 30 Jun 2025 | 1,066,721 |
| Bamco Inc /Ny/ | 30 Jun 2025 | 907,537 |
| William Blair Investment Management, Llc | 30 Jun 2025 | 865,244 |
| Balyasny Asset Management L.P. | 30 Jun 2025 | 488,688 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 70.00 (Mizuho, 57.66%) | Buy |
| Median | 65.00 (46.40%) | |
| Low | 60.00 (Canaccord Genuity, 35.14%) | Buy |
| Average | 65.00 (46.40%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 41.38 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Canaccord Genuity | 20 Aug 2025 | 60.00 (35.14%) | Buy | 39.09 |
| Mizuho | 16 Jul 2025 | 70.00 (57.66%) | Buy | 43.66 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 14 Oct 2025 | Announcement | Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal |
| 09 Oct 2025 | Announcement | Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report |
| 07 Aug 2025 | Announcement | Establishment Labs Reports Second Quarter 2025 Financial Results |
| 25 Jul 2025 | Announcement | Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |